Last €29.28 EUR
Change Today +1.38 / 4.93%
Volume 90.0
AB3A On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:26 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

Insiders at sarepta therapeutics inc (AB3A)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Christopher Garabedian 6 RelationshipsChief Executive Officer, President and Director--45

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
William Goolsbee 6 Relationships--Sarepta Therapeutics, Inc.58
John Hodgman B.S., M.B.A. 6 Relationships--InterMune Inc.57
Gil Price M.D. 6 Relationships--Accelovance, Inc.56
Hans Wigzell M.D., Ph.D. 119 Relationships--Finnish Society of Sciences and Letters74
M. Behrens Ph.D. 20 Relationships--RS Investment Management Co. LLC60
Anthony Chase 169 Relationships--ChaseSource LP57
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AB3A:GR €29.28 EUR +1.38

AB3A Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Agenus Inc $4.07 USD -0.05
Alnylam Pharmaceuticals Inc $28.98 USD +0.92
Hemispherx Biopharma Inc $0.20 USD -0.0005
Inovio Pharmaceuticals Inc $0.71 USD +0.02
Tekmira Pharmaceuticals Corp C$4.85 CAD +0.01
View Industry Companies
 

Industry Analysis

AB3A

Industry Average

Valuation AB3A Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 39.3x
Price/Book 13.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 33.9x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAREPTA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.